Evommune reports top-line results from EVO756 phase 2b clinical trials in moderate-to-severe atopic dermatitis: Palo Alto, California Thursday, September 10, 2026, 18:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results